HIV reverse transcriptase structures: Designing new inhibitors and understanding mechanisms of drug resistance

Trends in Pharmacological Sciences

Volumn 26, Issue 1, 2005, Pages 4-7

  Ren, Jingshan ^a   Stammers, David K ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BENZOIC ACID DERIVATIVE; CP 94707; ETRAVIRINE; GW 678248; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; UNCLASSIFIED DRUG;

CRYSTAL STRUCTURE; DATA ANALYSIS; DRUG RESISTANCE; DRUG TARGETING; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 11144233697     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2004.11.003     Document Type: Short Survey

References (18)

1. J. Ren High resolution structures of HIV-1 RT from four RT-inhibitor complexes Nat. Struct. Biol. 2 1995 293 302
2. Parikh, U. et al. (2002) Mutations in retroviral genes associated with drug resistance. http://www.hiv.lanl.gov/content/hiv-db/COMPENDIUM/2002/partI/ Resistance.pdf
3. B.A. Larder, and S.D. Kemp Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT) Science 246 1989 1155 1158
4. P.R. Meyer A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase Mol. Cell 4 1999 35 43
5. N. Sluis-Cremer Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs) Cell. Mol. Life Sci. 57 2000 1408 1422
6. K. Das Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants J. Med. Chem. 47 2004 2550 2560
7. D.K. Stammers Structural studies of benzophenone/HIV-1 RT complexes: insights into the potency of the next generation NNRTIs against WT and mutant HIV-1 Antiviral Therapy 9 2004 S36
8. H. Huang Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance Science 282 1998 1669 1675
9. J.D. Pata Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors Proc. Natl. Acad. Sci. U. S. A. 101 2004 10548 10553
10. S. Tuske Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir Nat Struct Mol Biol 11 2004 469 474
11. D.W. Rodgers The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1 Proc. Natl. Acad. Sci. U. S. A. 92 1995 1222 1226
12. R. Esnouf Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors Nat. Struct. Biol. 2 1995 303 308
13. A.L. Hopkins Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors J. Med. Chem. 39 1996 1589 1600
14. L.A. Kohlstaedt Crystal structure at 3.5Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor Science 256 1992 1783 1790
15. J. Ren Crystal structures of HIV-1 reverse transcriptase mutated at codons 100, 106 and 108 and mechanisms of resistance to non-nucleoside inhibitors J. Mol. Biol. 336 2004 569 578
16. H. Pelemans Mutational analysis of trp-229 of human immunodeficiency virus type 1 reverse transcriptase (RT) identifies this amino acid residue as a prime target for the rational design of new non-nucleoside RT inhibitors Mol. Pharmacol. 57 2000 954 960
17. Y. Hsiou The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance J. Mol. Biol. 309 2001 437 445
18. S.G. Sarafianos Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA EMBO J. 21 2002 6614 6624